Trump unveils deal to expand coverage and lower costs on obesity drugs Wegovy and Zepbound
WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to…
Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in Study
Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Pfizer (PFE) earnings Q3 2025
Pfizer CEO Albert Bourla speaks during a press conference after a visit to oversee the production of the…
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
Why an Old Multiple Sclerosis Drug Costs More Than Ever in the US
When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year.…
Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price comments
Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to…
Wells Fargo, Pfizer CEOs warn U.S. could lose out to China without innovation
Albert Bourla, CEO of Pfizer, Charlie Scharf, Wells Fargo & Company CEO and Kathy Warden, Northrop Grumman Chair…
AstraZeneca to cut Medicaid drug costs under Trump deal
WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to…
Trump reaches drug pricing deal with AstraZeneca
U.S. President Donald Trump participates in a bilateral meeting with Finland’s President Alexander Stubb (not pictured), in the…
Trump pharmaceutical tariff threat lessens after Pfizer deal
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with…